RhoGAM NCLEX Questions With Rationales

RhoGAM NCLEX questions test whether you can identify the unsensitized Rh-negative pregnant client who needs Rh immune globulin before maternal anti-D antibodies form. The priority is not just remembering 28 weeks and within 72 hours postpartum. The nurse must check maternal Rh status, antibody screen results, fetal or newborn Rh status when known, and whether a bleeding, trauma, procedure, pregnancy loss, or delivery event could mix fetal and maternal blood.

Use this practice set to think through the NCLEX decision tree. RhoGAM is given to the mother, not the newborn. It prevents Rh(D) alloimmunization; it does not treat an already sensitized pregnancy or fetal anemia that is already developing.

Quick NCLEX Answer

The classic NCLEX answer: administer Rh immune globulin to an unsensitized Rh-negative pregnant client at about 28 weeks and within 72 hours after delivery if the newborn is Rh-positive.

The key caveat: Rh immune globulin is also expected after events that can cause fetomaternal blood mixing, such as amniocentesis, chorionic villus sampling, external cephalic version, abdominal trauma, antepartum bleeding, ectopic pregnancy, later pregnancy loss, or suspected fetomaternal hemorrhage. For very early pregnancy loss or abortion, current guidance and facility policy can vary, so NCLEX stems usually make the expected action clear.

The safest test-taking cue: RhoGAM is for the unsensitized Rh-negative mother before her immune system makes true anti-D antibodies.

How Rh Incompatibility Shows Up on NCLEX

Rh factor is a red blood cell antigen. If an Rh-negative pregnant client carries an Rh-positive fetus, fetal red blood cells can enter the maternal circulation. The maternal immune system may then form anti-D antibodies. In a later Rh-positive pregnancy, those antibodies can cross the placenta and destroy fetal red blood cells, causing hemolytic disease of the fetus and newborn.

The NCLEX safety issue is prevention. The nurse recognizes who is at risk, verifies the right labs, gives the immune globulin to the correct client, and questions unsafe or unnecessary administration. If the client is already sensitized, the priority changes to provider-directed monitoring, antibody titers, and fetal anemia surveillance rather than routine prophylaxis as the solution.

RhoGAM Decision Tree for NCLEX

1. Check maternal Rh type. Rh-positive pregnant clients do not need Rh immune globulin for Rh(D) pregnancy prevention.
2. If the mother is Rh-negative, check the antibody screen. A negative indirect Coombs or negative antibody screen supports that the client is unsensitized.
3. If the client is already truly sensitized to D antigen, RhoGAM will not help. It prevents antibody formation; it does not remove established antibodies.
4. If unsensitized and fetal or newborn Rh status is positive or unknown, anticipate Rh immune globulin. This applies to routine prophylaxis, delivery, and sensitizing events.
5. Postpartum, give the dose to the mother within 72 hours if the newborn is Rh-positive or not confirmed Rh-negative. Do not inject the newborn.
6. Screen for medication safety issues. A history of anaphylactic or severe systemic reaction to human immune globulin products requires provider review before administration.

Timing and Lab Cues

RhoGAM NCLEX Practice Questions

These are original educational practice questions, not official NCLEX items. Answer first, then read the rationale and memory cue.

Question 1: Standard Multiple Choice

A pregnant client at 28 weeks has blood type A negative and a negative antibody screen. The fetus Rh type is unknown. Which prescription should the nurse anticipate?

1. Administer Rh immune globulin to the client.
2. Administer Rh immune globulin to the fetus.
3. Withhold Rh immune globulin because delivery has not occurred.
4. Prepare treatment for established fetal anemia.

Correct answer: 1. An Rh-negative, unsensitized client at about 28 weeks should receive routine antepartum Rh immune globulin if the fetus could be Rh-positive. The medication is maternal prophylaxis. It is not injected into the fetus, and it is not treatment for existing fetal anemia. Memory cue: Rh-negative plus antibody screen negative means prevent sensitization before exposure causes anti-D formation.

Question 2: Postpartum Dose

A client who is Rh-negative received RhoGAM at 28 weeks. The client delivers a newborn with blood type O positive. Which action is correct?

1. No additional dose is needed because one was given at 28 weeks.
2. Give Rh immune globulin to the mother within 72 hours after birth.
3. Give Rh immune globulin to the newborn before discharge.
4. Give Rh immune globulin only if the newborn has jaundice.

Correct answer: 2. The antepartum dose does not replace the postpartum dose. If an Rh-negative mother delivers an Rh-positive newborn, the postpartum dose is given to the mother within 72 hours. Newborn jaundice may require assessment and treatment, but it is not the indication for injecting the newborn with RhoGAM. Memory cue: 28 weeks is prevention during pregnancy; 72 hours postpartum is prevention after delivery exposure.

Question 3: Who Does Not Need RhoGAM?

Which client would the nurse expect not to need Rh immune globulin for Rh(D) pregnancy prevention?

1. Rh-negative client with a negative antibody screen after amniocentesis
2. Rh-negative client at 28 weeks with unknown fetal Rh status
3. Rh-positive client after delivering an Rh-negative newborn
4. Rh-negative client after abdominal trauma at 30 weeks

Correct answer: 3. An Rh-positive mother does not need Rh immune globulin to prevent Rh(D) alloimmunization. The other clients are Rh-negative and have either routine timing or a sensitizing event. Memory cue: Start with the mother, not the baby. Maternal Rh status drives the first decision.

Question 4: Antibody Screen Trap

A client is Rh-negative at 24 weeks. The antibody screen shows true anti-D alloimmunization. Which statement best explains the expected plan?

1. Give RhoGAM immediately to remove the anti-D antibodies.
2. Give RhoGAM to the fetus to prevent hemolysis.
3. Notify the provider and anticipate monitoring for alloimmunized pregnancy.
4. Ignore the result because sensitization can occur only after delivery.

Correct answer: 3. RhoGAM prevents anti-D antibody formation in an unsensitized client. It does not remove true maternal anti-D antibodies once sensitization has occurred. Management may include antibody titers and fetal monitoring for anemia risk. Memory cue: RhoGAM prevents the problem; it does not undo the problem.

Question 5: Procedure Exposure

An Rh-negative client with a negative antibody screen has an amniocentesis at 16 weeks. Which nursing action is most appropriate?

1. Anticipate Rh immune globulin because the procedure can cause fetomaternal blood mixing.
2. Teach that RhoGAM is used only after live birth.
3. Ask the provider to order RhoGAM for the newborn.
4. Withhold RhoGAM because the client is in the second trimester.

Correct answer: 1. Invasive procedures such as amniocentesis and chorionic villus sampling can allow fetal red blood cells to enter the maternal circulation. An unsensitized Rh-negative client should receive prophylaxis according to the prescription and facility policy. Memory cue: Procedures can count as exposure events even before delivery.

Question 6: Priority After Trauma

A client at 31 weeks reports being hit in the abdomen during a fall. The client is Rh-negative and previously had a negative antibody screen. Which action should the nurse anticipate in addition to maternal and fetal assessment?

1. Rh immune globulin administration as prescribed
2. Discharge without follow-up if pain resolves
3. Rh immune globulin for the fetus only
4. Delay all care until the newborn blood type is known after delivery

Correct answer: 1. Abdominal trauma can cause fetomaternal hemorrhage. The nurse still prioritizes maternal and fetal assessment, but Rh immune globulin is expected for an unsensitized Rh-negative client after possible fetal red blood cell exposure. Memory cue: Bleeding risk plus Rh-negative status means think exposure prevention.

Question 7: Select All That Apply

Which situations may require Rh immune globulin for an unsensitized Rh-negative pregnant client? Select all that apply.

1. Routine prophylaxis at about 28 weeks
2. Delivery of an Rh-positive newborn
3. Chorionic villus sampling
4. External cephalic version
5. Antepartum vaginal bleeding from placenta previa
6. Maternal blood type B positive with Rh-negative newborn

Correct answers: 1, 2, 3, 4, and 5. Routine prophylaxis, Rh-positive delivery, invasive testing, obstetric manipulation, and antepartum bleeding are high-yield indications in NCLEX-style questions. Choice 6 is wrong because the mother is Rh-positive. Memory cue: Ask whether an Rh-negative, unsensitized mother could be exposed to Rh-positive fetal red blood cells.

Question 8: Select All That Apply

Which statements by a nursing student about RhoGAM require correction? Select all that apply.

1. RhoGAM is given to the mother after delivery if the newborn is Rh-positive.
2. RhoGAM prevents ABO incompatibility.
3. RhoGAM is useful after a mother has already developed true anti-D antibodies.
4. The postpartum dose is not needed if the mother received it at 28 weeks.
5. RhoGAM may be indicated after amniocentesis or abdominal trauma.
6. A negative indirect Coombs supports that the mother is not sensitized.

Correct answers: 2, 3, and 4. RhoGAM prevents Rh(D) sensitization, not ABO incompatibility. It is not useful once true anti-D alloimmunization is established. A postpartum dose is still needed after delivery of an Rh-positive newborn even if an antepartum dose was given. Statements 1, 5, and 6 are accurate. Memory cue: Do not let one correct timing fact erase the rest of the decision tree.

Question 9: Lab Interpretation

Which lab result is most important before giving routine antepartum Rh immune globulin to an Rh-negative pregnant client?

1. Maternal antibody screen or indirect Coombs result
2. Newborn direct Coombs result
3. Maternal fasting glucose only
4. Newborn bilirubin level after birth

Correct answer: 1. The maternal antibody screen, also called the indirect Coombs test in many NCLEX resources, helps determine whether the client is already sensitized. Newborn direct Coombs and bilirubin are relevant after birth when evaluating neonatal hemolysis, but they are not the pre-administration screen for maternal prophylaxis at 28 weeks. Memory cue: Indirect Coombs checks maternal antibodies; direct Coombs checks antibodies attached to newborn red blood cells.

Question 10: Question the Prescription

The nurse reviews prescriptions for four clients. Which prescription should the nurse question?

1. Rh immune globulin for an Rh-negative client after amniocentesis
2. Rh immune globulin for an Rh-negative mother after delivery of an Rh-positive newborn
3. Rh immune globulin for an Rh-positive mother after delivery of an Rh-negative newborn
4. Rh immune globulin for an Rh-negative client after abdominal trauma

Correct answer: 3. Rh immune globulin is not indicated for an Rh-positive mother for Rh(D) pregnancy prevention. The other prescriptions match common exposure or postpartum indications for an Rh-negative mother. Memory cue: The unsafe order is the one that ignores maternal Rh-positive status.

Question 11: Large Fetomaternal Hemorrhage

An Rh-negative postpartum client delivered an Rh-positive newborn. Screening suggests a large fetomaternal hemorrhage. Which action should the nurse anticipate?

1. Cancel Rh immune globulin because the exposure was too large.
2. Give only a newborn dose of RhoGAM.
3. Use additional testing to guide whether extra maternal dosing is needed.
4. Withhold care until the next pregnancy.

Correct answer: 3. A standard 300 mcg dose covers a defined amount of Rh-positive red blood cell exposure, and larger fetomaternal hemorrhage can require additional dosing. Tests such as Kleihauer-Betke testing or flow cytometry may help quantify fetal blood and guide dosing. Memory cue: Large exposure does not cancel prevention; it may increase the amount needed.

Question 12: Matrix-Style Item

Classify each client as likely needing or not needing Rh immune globulin for the situation described.

Rationale: Matrix items reward a consistent process. Check the mother first, then sensitization status, then exposure risk or newborn Rh status.

Question 13: Bow-Tie Style Item

A 26-year-old client at 29 weeks is blood type O negative. The antibody screen is negative. The client has bright red vaginal bleeding related to placenta previa and is being monitored. Complete the clinical judgment pattern.

Rationale: The immediate clinical issue includes bleeding and fetal monitoring, but the Rh-specific NCLEX action is prevention of sensitization in an Rh-negative, unsensitized client. RhoGAM is not the treatment for placenta previa bleeding; it addresses the immune exposure risk.

Question 14: Unfolding Case Part 1

A client at 28 weeks has blood type AB negative and a negative antibody screen. The provider prescribes Rh immune globulin. Which teaching is best?

1. This medication helps prevent your immune system from forming antibodies against Rh-positive fetal blood cells.
2. This medication treats fetal anemia that has already occurred.
3. This injection is for your baby after birth, not for you.
4. This medication prevents all blood type incompatibility problems.

Correct answer: 1. Rh immune globulin provides passive anti-D to prevent maternal sensitization to Rh(D). It does not treat established fetal anemia, it is given to the mother, and it does not prevent ABO incompatibility. Memory cue: The teaching should match prevention, mother, and anti-D.

Question 15: Unfolding Case Part 2

Two weeks later, the same client reports a minor motor vehicle crash with abdominal impact. Maternal vital signs are stable, fetal monitoring is ordered, and the provider asks about Rh status. What should the nurse recognize?

1. No Rh follow-up is needed because the client already received RhoGAM at 28 weeks.
2. Rh immune globulin may be needed after trauma because exposure can occur before delivery.
3. The newborn should receive RhoGAM immediately.
4. Rh immune globulin is needed only if the mother is Rh-positive.

Correct answer: 2. Trauma is a sensitizing event. Prior routine prophylaxis does not automatically eliminate the need for evaluation and possible additional prophylaxis after a new exposure. The newborn does not receive RhoGAM, and Rh-positive mothers do not need it for Rh(D) pregnancy prevention. Memory cue: New exposure event means reassess the need for prophylaxis.

Question 16: Unfolding Case Part 3

The client later delivers a newborn with blood type AB positive. Which action is expected?

1. Administer Rh immune globulin to the mother within 72 hours postpartum.
2. Withhold Rh immune globulin because the newborn is stable.
3. Administer Rh immune globulin to the newborn.
4. Give Rh immune globulin only if the newborn direct Coombs is negative.

Correct answer: 1. An Rh-negative mother who delivers an Rh-positive newborn should receive postpartum Rh immune globulin within 72 hours. Newborn stability does not remove the maternal sensitization risk. The direct Coombs may help evaluate neonatal hemolysis, but postpartum maternal prophylaxis is based on maternal Rh status, sensitization status, and newborn Rh type. Memory cue: Rh-positive baby after Rh-negative mother means maternal postpartum dose.

Common RhoGAM NCLEX Traps

• Giving it to the newborn: postpartum RhoGAM is administered to the mother.
• Using it after true sensitization: RhoGAM prevents anti-D formation but does not remove established antibodies.
• Stopping at 28 weeks: the postpartum dose is still needed after an Rh-positive delivery.
• Ignoring procedures or trauma: amniocentesis, CVS, external cephalic version, bleeding, trauma, ectopic pregnancy, and later pregnancy loss can be exposure events. Early pregnancy loss and abortion recommendations vary, so read the stem closely.
• Confusing Rh and ABO: Rh immune globulin prevents Rh(D) alloimmunization, not ABO incompatibility.
• Misreading Coombs tests: indirect Coombs or antibody screen evaluates maternal antibodies; direct Coombs evaluates antibodies attached to neonatal red blood cells.
• Forgetting large hemorrhage dosing: significant fetomaternal hemorrhage may require testing and extra maternal dosing.

FAQs

When is RhoGAM given in NCLEX questions?

The classic timing is about 28 weeks during pregnancy and within 72 hours after delivery if the newborn is Rh-positive. It may also be given within 72 hours after sensitizing events such as amniocentesis, CVS, external cephalic version, bleeding, trauma, ectopic pregnancy, later pregnancy loss, or suspected fetomaternal hemorrhage. Early pregnancy loss and abortion guidance varies by gestational age, guideline, and facility policy, so use the details in the NCLEX stem.

Which mother gets RhoGAM?

The NCLEX pattern is an Rh-negative mother who is not already sensitized and whose fetus or newborn is Rh-positive or could be Rh-positive. A negative antibody screen supports prophylaxis. The nurse should verify provider orders and facility policy for the clinical situation.

Does an Rh-positive mother need RhoGAM?

No, not for Rh(D) pregnancy prevention. The medication is used to prevent an Rh-negative person from forming anti-D antibodies after exposure or possible exposure to Rh-positive red blood cells.

Does the baby receive RhoGAM?

No. In postpartum maternity questions, RhoGAM is given to the mother. Giving it to the newborn is a common wrong answer.

Why is RhoGAM given at 28 weeks?

It is given because fetal red blood cells can enter maternal circulation during pregnancy, not only during delivery. Many NCLEX resources teach 28 weeks. The RhoGAM prescribing information describes antepartum prophylaxis at 26 to 28 weeks, so follow the wording in the item and facility policy in practice.

Is RhoGAM needed if the baby is Rh-negative?

If the newborn is conclusively Rh-negative, postpartum Rh(D) exposure is not present, so postpartum Rh immune globulin is generally not needed for that delivery. If the newborn Rh status is unknown, the NCLEX stem may expect prophylaxis until Rh-negative status is confirmed.

Is RhoGAM needed if the antibody screen is positive?

It depends on why it is positive. A true anti-D alloimmunization means RhoGAM will not help because the client is already sensitized. Recent Rh immune globulin can sometimes cause passive anti-D on testing, so clinical interpretation belongs with the provider, blood bank, and facility policy.

What is the difference between indirect and direct Coombs in RhoGAM questions?

The indirect Coombs or antibody screen checks for maternal antibodies in the blood and helps determine whether the mother is sensitized. The direct Coombs test checks whether antibodies are attached to newborn red blood cells. Do not use a newborn direct Coombs result as a reason to give RhoGAM to the newborn.

Does the mother need postpartum RhoGAM if she already received it during pregnancy?

Yes, if she is Rh-negative, not already truly sensitized, and delivers an Rh-positive newborn. The 28-week dose and postpartum dose address different exposure periods.

Can RhoGAM interact with vaccines?

Immune globulin products can interfere with response to some live-virus vaccines, so timing may be adjusted based on prescribing information and facility policy. The prescribing information notes that postpartum rubella or MMR vaccination should not be delayed solely because Rh immune globulin was given. For NCLEX, this is usually a teaching and safety caveat, not the main decision point.

Sources and Currentness

This draft reflects research reviewed on May 16, 2026. It uses NCSBN 2026 NCLEX-RN and NCLEX-PN test plan framing effective April 1, 2026, through March 31, 2029; RhoGAM Ultra-Filtered PLUS prescribing information; ACOG guidance summaries and patient education on Rh factor; Merck Manual Professional and Consumer content on hemolytic disease of the fetus and newborn and Rh incompatibility; and Cleveland Clinic patient education for general Rh factor explanation. In clinical practice, follow current prescribing information, obstetric provider orders, blood bank guidance, and facility policy.